Larvol Delta - Caribou-Biosciences-Announces-the-FDA-Granted-Regenerative-Medicine-Advanced-Therapy-RMAT-Designation-to-CB011-an-Allogeneic-AntiBCMA-CART-Cell-Therapy

CB-011 - Caribou Biosci

https://www.manilatimes.net/2026/03/31/tmt-newswire/globenewswire/caribou-biosciences-announces-the-fda-granted-regenerative-medicine-advanced-therapy-rmat-designation-to-cb-011-an-allogeneic-anti-bcma-car-t-cell-therapy/2311421

Mar 31, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next